• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Boston Scientific to sell BTG Specialty Pharmaceuticals business for $800m pharmaceutical-technology
    December 03, 2020
    Boston Scientific has signed a definitive agreement with SERB’s affiliates, Stark International and SERB SAS, to divest its BTG Specialty Pharmaceuticals business for $800m in cash.
  • Recipharm, SERB Enter Agreement contractpharma
    June 19, 2018
    Recipharm has signed and closed an agreement with SERB SA (“SERB”) on a divestment of its rights to its potassium iodide product ThyroSafe® except for the US territory. 

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service